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A B S T R A C TOver the past 20 years, Colombia has invested major efforts in
ensuring universal health care access to its citizens while facing
epidemiological transition and demographic changes. The country, as
any other region in the world, is challenged by financial constraints
and market pressures for entry of new and frequently costly technol-
ogies. After the 1993 health sector reform, Colombian citizens are
entitled to health care access via mandatory health insurance through
a benefits plan. Inclusions to this plan were the first attempt to
establish a formal methodology of health technology assessment.
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ondence to: Nicolas Vargas Zea, ISPOR Colombia, 13decisions, and judicial actions drove the government toward the
formulation of an infrastructure to improve efficiency in the use of
resources. This article accounts for the steps undertaken by the
Colombian health system until the establishment of a health technol-
ogy assessment body and outlines the most important issues that can
be learned from this process.
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From 1993 Colombian citizens are entitled to health care access via
mandatory health insurance through a benefits plan [1]. Health
coverage as well as most performance indicators improved vastly,
but the country faced the issue of needing a rational strategy to
allocate resources. Between 2005 and 2010, the consumption of
nonincluded technologies increased at rates as high as 855.89% [2].
Alongside, judicial interventions became the most common means
for citizens to gain access to nonincluded technologies, a fact that has
threatened the financial sustainability of the system in the midterm.
Various actions over these past two decades have been under-
taken by current and past governments with the aim to control
costs and strengthen the system’s institutional capability to allo-
cate resources. It is only in the last 2 years that the formal methods
of health technology assessment (HTA) have seized the attention of
policymakers. Last January 2011, Colombia enacted by law its own
HTA agency, which is still under organizational design [3].
This article accounts for the steps undertaken by the Colom-
bian health system to achieve its aim to improve the allocation ofresources and describes how the health system reform (HSR) led
to the creation of the agency.Colombian Health System
Colombia is a middle-income economy with an estimated popu-
lation of 46.581.823 million inhabitants (22.997.087 men and
23.584.736 women) for the year 2012 [4]. Over the last 30 years,
Colombia has experienced demographic and epidemiological
changes such as a rapid decrease in total fertility rates, a
significant increase in life expectancy, and fast urbanization rates.
Before the HSR only a third of the population was covered by
social insurance, and more than half of the total expenditure for
health was attributable to out-of-pocket spending. In 1993, Colom-
bia launched the HSR that replaced the previously segmented and
low-coverage model. These changes prompted a competitive mar-
ket that included insurers and health care providers. According to
figures from the Ministry of Health and Social Protection , Colombia
reached a health coverage of 96% in 2011 Figs 1-3 [5].
Law 100 of 1993 unified public and private health systems into
one called the ‘‘General System of Social Security in Health’’ [1] .for Pharmacoeconomics and Outcomes Research (ISPOR).
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Fig. 1 – Colombian health system coverage. Source: Fedesarrollo, Ministry of Health, and Fund of Solidarity and Guarantees.
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rather than into groups of populations [6]. There is a contributive
regimen for those with ability to pay and a subsidized one for those
without it. The population covered by the subsidized regimen
(mostly unemployed) is selected on the basis of a survey performed
by the government. Funding of the system is based on a combina-
tion of social security and payroll taxes of formal employees.
Health care providers are both public and private in this
system, and all affiliates have access to a benefits plan defined
by the government periodically. Alongside the official list of
benefits, the system also reimburses more than 700 nonincluded
drugs and technologies that are claimed by patients through
exceptional mechanisms (judicial actions).
Insurers play a very important role by administering these benefits
plan to patients. At this moment, concentration is taking place in the
health sector and the smaller and less efficient insurers are being
absorbed by stronger competitors. Insurers operate with an insurance
premium known as the Capitation Payment Unit, an amount of
money transferred by the government for each individual enrolled inFig. 2 – Colombian healtheach company. In 2012, there was a differential unit between the two
regimens: $304.24 USD per year for the contributive regime and
$240.94 USD per year for the subsidized regime, a fact that con-
tributed to inequity within the system. This premium is adjusted
against epidemiological variables and geographical differences [7].
There are also supplementary (voluntary) health insurances
known as prepaid medicine, all of which offer additional coverage
to the basic benefits plan. These plans are completely funded from
private spending [1]. The system also comprises coverage for special
populations such as military forces, public education workers, and
the national oil company employees, all of whom have different
benefits plans and do not pool their resources within the system.
Finally, there is a Basic Health Plan that addresses public health
issues and covers all citizens regardless of their insurance status.
Municipalities and local health authorities provide health promotion
and disease prevention programs through the BPH. BPH is funded
from alternative sources than those of the general system. There are
two complementary plans that cover health care services derived
from road accidents and natural disasters.system composition.
Fig. 3 – Stakeholders involved in the eventual HTA process. HTA, health technology assessment.
VA L U E I N H E A LT H R E G I O N A L I S S U E S 1 ( 2 0 1 2 ) 2 1 8 – 2 2 2220According to the World Bank, Colombian spending on health in
2010 was nearly 7.6% of the gross domestic product and Colombia
was one of the Latin American countries that expend more in
health as a percentage of the gross domestic product. The HSR
separated funding from health care delivery and gave an impor-
tant stimulus to the creation of private health institutions [8].The Efforts Invested Aimed at Improving Allocation Efficiency
Over the Past Two Decades
This section accounts for the steps undertaken by the Colombian
system to conduct and use HTA to inform decision making. From
early nonsystematic methodological approaches to early
attempts at institutionalization to the recent enactment of its
own HTA agency, this section describes the incremental process
of policy making toward the use of HTA.Mechanisms for Updating the Benefits Plan (1998–2007)
From 1998 to 2000, no updates were made to the plan (with the
exception of Decree 806/1998 [9]). From 2000 to 2006, only specific
inclusions were made. Before 2002, update proposals were pre-
pared and presented by the National Council for Social Security
to the Ministry of Health (MOH).
In 2002, the Health Technology and Medicines Committee was
set up to support the former and the general council [10] . This new
committee, however, found it challenging to meet its remit because
of methodological and financing issues (e.g., lack of resources for
commissioning research, organizing meetings, and rewarding its
members). As a result, the MOH progressively took over council’s
responsibilities for updating the plan, some of which included
commissioning research to inform such updates (a role later
transferred to the Health Regulatory Commission [CRES]) [11].Draft of HTA Legislation (2004)
In 2004, the creation of an HTA coordination center at the MOH and
a technical advisory committee to assist the committee were
proposed. It considered stakeholders at three levels: macro MOH,
Ministry of Finance, National Council for Social Security (now
CRES), National Institute for Surveillance of Medicines and Food
(Instituto Nacional de Vigilancia de Medicamentos y Alimentos),
National Department for Planning, regional health secretariats;meso (insurers, providers, and industry); and micro (professionals,
patients and their families, and community).
By this moment, judicial actions were becoming the most
important medium of access for nonincluded technologies. But it
was only in 2004 that technical scientific committees were
created to try to filter and control these actions. Ministerial
Resolution 3797 [12] regulated submissions of nonincluded ser-
vices, and all insurers were obliged to form their committees.
The burden of disease between different subpopulationswas very
different and adverse selection among insurers became an issue that
the government had to control. Therefore, Decree 2699 of 2007
created the National Account of High Cost, as an effort to adjust
for primary risk and adverse selection among insurers of cata-
strophic spending cases; this account is administered by insurers.
Chronic renal failure and HIV/AIDS among otherswere considered as
catastrophic diseases by Decree 5261 of 1994 [13]. After piloting in
2008, the committee started operations focused on renal failure but
subsequently added diseases including cervical, breast, stomach,
colorectal, and prostate cancers, acute lymphoid leukemia, acute
myeloid leukemia, Hodgkin and non-Hodgkin lymphomas, epilepsy,
and rheumatoid arthritis to the list.
From 2006 onward, evidence-based clinical guidelines were
introduced for HIV/AIDS, chronic renal failure, and family plan-
ning for both regimes (contributory and subsidized), and for type
2 diabetes and hypertension for the subsidized one [14].
National Plan for Public Health (2007–2010)
By Presidential Decree 3039 of 2007, the MOH adopted the National
Plan for Public Health, which established main priorities such as
neonatal care, sexual and reproductive health, oral health, mental
health, communicable diseases, chronic noncommunicable dis-
eases, disabilities, nutrition, health, and safety at the workplace
and enhancement and strengthening of national public health. The
technical mechanisms used to choose over priorities are not clear.
Creation of the Health Regulatory Commission In 2007, by Law 1122 [11], the Health Regulatory Commission
was created as an autonomous, special unit, ascribed to the
MOH, responsible for updating contents of the benefits
plan. Over the past 3 years, this commission has worked toward
the establishment of a methodology for HTA and its appraisal.
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Judges at local and regional levels have been involved in decision
making within the health sector from late 1990s and early 2000s
onward. Judicial actions have ordered the provision of services not
explicitly included in the benefits package at the expense of
health system’s funds. According to figures from ‘‘Defensoria del
Pueblo’’ (People’s advocates), in 2005 there weremore than 250,000
judicial actions, 36% of them directly related to health care [15].
According to official data from the MOH, 86.9% of exceptionally
reimbursed costs in 2009 (Col $1.7 billion) were derived from
nonincluded services within the contributory regimen [16].
In late 2008, the Constitutional Court’s mandate analyzed 22
judicial actions cases and ordered the executive (MOH, CRES,
Committee and National Superintendence for Health) to address
structural issues that have threatened equity, financial stability,
and control of the reimbursement process. To comply with this
mandate, an additional Col $350,000 million were added to the
total budget for health in 2008 and Col $585,000 million in 2009. A
number of institutional reforms have taken place as well as part
of the effort to improve efficiency within this health system.
In 2009, the Health Regulatory Commission [17] proposed three
courses of action as policy solutions: 1) To gather information and
relevant data for priority setting (national health surveys, burden of
disease, actuarial analysis of insurance premiums, cost and utiliza-
tion analyses, inputs from relevant stakeholders); 2) To carry out
prioritization of services and technologies (stakeholder consulta-
tion, evidence-based clinical guidelines, introduce new coding
methods to increase reliability of data, and to strengthen the
communication strategy); and 3) institutional strengthening. This
commission updated the benefits plan last December 2011, but its
methods were resisted because of the methodological weakness on
the application of HTA principles. Nevertheless, an important
process of consultation with citizenswas performed and first efforts
to debate issues such as prioritization, inclusion or exclusion of
technologies, and budget assessments were made.
Law 1438 as a New Attempt of an HSR (2011)
In January 2011, Law 1438 was enacted as an effort to put together
different policy solutions to a list of structural weaknesses within
the health sector [3]. It aimed at pursuing universal coverage,
portability of entitlement, equalization of benefit plans, institu-
tional strengthening, and financial sustainability. This law com-
mands the government every 4 years to evaluate the macro-level
performance of the health system. With regard to priority setting,
the more remarkable articles of the law state the following: The National Observatory for Health is created to monitor
relevant indicators of public health, provide technical support
to national-level authorities, improve epidemiological data,
advise the MOH and CRES, and report to the Congress key
performance indicators (Article 8). It enquired the regulatory commission to update the benefits
plan for children and adolescents (Article 17). Allowed insurers to enroll citizens from both regimens.
 Mandates benefits plan to be updated every 2 years, using
epidemiological data, burden of disease, and budget and
financial considerations. Mandates that methods to be used for updating the benefits
plan should be clear and transparent and with stakeholder
engagement (provider’s organizations, professional bodies, ser-
vice users, scientific societies, and other relevant stakeholders). Mandates that decision making on reimbursement should be
made only by the administrative authority responsible for these
matters with the first update to be completed by December 2011. Required that every prescription of nonincluded services and
technologies ought to be assessed by technical scientificcommittees in an independent manner.
 Creates the Technical Scientific Board of Peer Reviewers to assess
each physician’s nonincluded prescription (both approved and
denied by the committee) within 7 days of submission. Establishes a new national policy for medicines, medical
supplies, and devices, to improve efficiency, equity of access,
and quality. A new National Commission for Prices of Medi-
cines and Medical Devices will be in charge of price regulation
for medicines and devices. The MOH will establish a price
negotiation mechanism for medicines and devices on the
basis of reference pricing, and IPS will not be allowed to pay
above these reference prices.The legal entitlement to the MOH to create the Institute for
Health Technology Assessment [3]
Colombia experienced a process of transition for HTA assess-
ments and appraisals. Market pressures and innovation process
within the industry made these types of evidence available for
various stakeholders, and yet the structure was not entirely
assumed. The creation of the IETS is a first step toward the
consolidation of local evidence and the empowering of decision
makers.
The most important aspects of this new agency are (for now)
entitled by law and will be as follows: IETS’s objectives will be to develop the HTA process on the
basis of safety, efficacy, effectiveness, utility, and economic
impact of the technologies evaluated. IETS will be the body to ensure assessment of evidence and
will return evidence to the MOH for it to be the appraisal
organization. IETS will be a not-for-profit, public-private organization that
may include, among others, scientific societies and the
Colombian Academy of Medicine. IETS will develop evidence-based HTA, clinical guidelines, and
protocols to guide the use of medical procedures and medi-
cines, influencing decisions about medical pertinence. IETS will make use of accredited centers for HTA at national
and international levels.Discussion
The case of the Colombian health system provides information
on how context, policy, and political challenges and solutions
could incrementally lead to the systematic use of evidence to
inform health policy. The country’s financial constraints, com-
peting priorities, fragmentation, and citizens’ tradition to chal-
lenge health care coverage, as well as the lack of institutional
capacity, led the government to enact by law a new HTA agency.
It is expected that the agency in its beginning will attend to
technical issues such as the prioritization of technologies, crea-
tion of local data, relevance of modeling (health economic
models, quality-adjusted life-years, expert elicitation, etc.), role
of real-life studies, whether there is a specific threshold, the
relevance of budget impact analysis, and so on.
The interaction between all the relevant governmental bodies
and the flow of information between them will be a key factor
that needs to be taken into account for the assessment of the
impact of the agency’s role. Whether the recommendations of the
agency will be in the form of guidance or mandatory and which
groups would be targeted to implement are issues that heavily
rely on communication between bodies.
There is a certain development in many countries to move from
a pure evidence-based decision making to a larger extent of
participation of patients, a larger focus on real-world data
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effectiveness. In this context, Colombia has experienced the quand-
aries of judicial actions within the core of the system and should
learn to integrate these experiences within the process of HTA.
The issue of reallocation of resources will also have to be
addressed not only by the agency but also by the government.
Kluge [18] states that the nature of medicine also plays a role in
resource allocation because there must be a coherent and con-
sistent model of the goods and services that are allocated by
members of the medical profession. Interactive and efficient
ways to integrate the medical profession into the process of
allocation sooner in the process rather than in the end or as a
result of an autonomous decision taken by governments should
be considered.
Colombia has assumed HTA as a path to improve efficiency in
the allocation of resources in the short term. Nevertheless,
challenges such as lack of capacity must be overcome for the
agency to have an influence over decision makers. Historical
efforts toward the creation of the architecture will also have to be
considered when the new agency starts to function.
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